false
Catalog
Nicotine and Stimulant Use in Adolescents
Presentation
Presentation
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this video, Dr. Nicholas Chadi, a pediatrician specialized in adolescent and addiction medicine, discusses nicotine and stimulant use in adolescents. He begins by providing an overview of the goals of the webinar, which include discussing recent trends in nicotine and stimulant use, describing the health risks associated with these substances, and exploring evidence-based treatment options for youth.<br /><br />Dr. Chadi then goes on to discuss various forms of nicotine products, such as e-cigarettes, cigars, and smokeless tobacco. He explains the health risks associated with nicotine use, including the potential for addiction and the harmful effects of nicotine on the developing adolescent brain.<br /><br />Next, he shifts gears to discuss illicit stimulants, such as cocaine, ecstasy, and methamphetamine. He outlines the short-term and long-term effects of these substances and highlights the potential risks and harms associated with their use.<br /><br />Dr. Chadi also addresses prescription stimulants, used primarily for treating attention deficit hyperactivity disorder (ADHD). He discusses the misuse and risks associated with these medications, as well as the importance of safe prescribing practices.<br /><br />Lastly, Dr. Chadi briefly touches on caffeine use in adolescents, noting its prevalence and potential risks. He emphasizes the need for caution and moderation when consuming caffeine, particularly in the form of energy drinks or caffeine powder.<br /><br />Throughout the video, Dr. Chadi provides evidence-based recommendations and insights for healthcare professionals working with adolescents who may be using nicotine or stimulants. He stresses the importance of screening, brief intervention, and utilizing evidence-based treatment approaches to address substance use in this population.<br /><br />The video concludes with acknowledgements and information about the PCSS Mentoring Program, which offers support and guidance to clinicians regarding evidence-based practices for opioid use disorder treatment.
Asset Subtitle
View the recorded presentation to attest that you have viewed the presentation in its entirety.
Keywords
Dr. Nicholas Chadi
adolescent
addiction medicine
nicotine use
stimulant use
health risks
e-cigarettes
illicit stimulants
prescription stimulants
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email
PCSS-MOUD
.
ORN
opioidresponsenetwork.org
×
Please select your language
1
English